Catalyst Wire Dossier Catalyst Wire Dossier

Lipocurc

· SignPath Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lipocurc, covering 2022-05-11 to 2022-05-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer [Phase 1, Phase 2]

See pricing